This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

In The Battle Against Rampant Diabetes, Reducing Hunger Hormone Ghrelin May Be The Ultimate Solution, Says Noted Surgeon Dr. Michael Feiz

LOS ANGELES, Feb. 1, 2013 /PRNewswire/ -- Renowned bariatric surgeon, Michael Feiz, M.D., F.A.C.S., has some thoughts on fighting the seemingly unstoppable spread of type 2 diabetes; it all comes down to reducing the body's production of a particular hormone through such procedures as gastric sleeve surgery. The ghrelin hormone appears to be responsible for sending hunger messages to the brain and may be the primary reason many of us often feel hungry even after we've eaten more than enough food. Evidence seems to suggest that overweight people, and especially overweight people who are attempting to lose weight through diet and exercise, may be more vulnerable to increased production of the hormone than others. Such highly effective bariatric procedures as the gastric sleeve remove 75-85% of the stomach, including the fundus area, the apparent center of the body's production of ghrelin.

In purportedly health-conscious California, the U.S. Center for Disease Control reports that diabetes rates jumped by 38% between 1995 and 2010, with a full 8.2% of the population now qualifying as diabetic. This is genuinely tragic, as type 2 diabetes can be even more devastating to individuals than you might already think. Type 2 diabetes not only threatens to shorten lifespans, but also basic quality of life – just ask the people who have lost limbs, their eyesight, or even major bodily organs such as kidneys.

It's no wonder then that, aside from the psychological and social factors which make weight loss desirable, more and more seriously overweight people are exploring every option available for weight loss and/or diabetes prevention. While such techniques as F.D.A. compliant lap band surgery and traditional diet and exercise can be highly effective, techniques that attack ghrelin at the source are looking more attractive than ever.

Of course, bariatric surgery is not appropriate for everyone and not all cases of type 2 diabetes are directly tied to excessive weight. Indeed, new studies are also showing that there is some chance that increased consumption of beta-carotene rich foods such as carrots may help delay the illness for those with a genetic predisposition. However, as the prevalence of diabetes continues to increase alongside the numbers of seriously obese Americans, reducing the power of the hormone which makes us overeat seems to potentially be the most promising anti-diabetes technique of all.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs